Study backs pulmonary delivery method for insulin
This article was originally published in Clinica
Administering insulin to Type 1 diabetics using Aradigm's AERx pulmonary delivery system shows faster absorption and onset of metabolic effects, compared with subcutaneous injection, according to data presented at the American Diabetes Association meeting in San Antonio, Texas, last week.
You may also be interested in...
Steve Niedelman of the law firm King & Spalding gave manufacturers a few words of advice when prepping their so-called front rooms, where US FDA investigators do the majority of their work during facility inspections. See what he said here.
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”